viernes, 30 de noviembre de 2018

Europe Expands Approval of Kalydeco to Certain CF Patients Ages 1-2

Europe Expands Approval of Kalydeco to Certain CF Patients Ages 1-2



Cystic Fibrosis News Today

European Union Expands Kalydeco’s Approval to Certain CF Patients Ages 1-2

No hay comentarios:

Publicar un comentario